Adverio Pharma GmbH
USPTO PatentsView assignee record - 21 granted patents across 7 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Adverio ranks #13,837 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 7 technology areas.
- #13,837
- of 49,997 US assignees by volume
- 39th percentile
- by Innovation Score (31.9/100)
- 13.5
- avg claims per patent
- +10%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R13837 · Foreign Corporation #13,837 · 21 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 21 grants
- MID-PACK #13,837/49,997
- PHOTO-FINISH Adasky
- CPC-NARROW A61P · 7 areas
- INNOV-THIN 31.9/100
- CLAIMS-RICH 13.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +10% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Adasky, Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Adverio’s 31.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Adverio
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Adverio Pharma · this assignee 32
Adverio Pharma · this assignee
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Adverio's Innovation Score is 31.9/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Adverio?
Each dot is one of Adverio’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Adverio’s own 13.5 claims/patent is at or below the 17.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Adverio's grants concentrate
Adverio Pharma GmbH is a focused PatentsView assignee: 7 CPC subclasses with 95.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2015. By volume, Adverio sits between Adasky, Ltd. and Allurion Technologies, LLC.
Adverio's three-year grant acceleration
Adverio Pharma GmbH shows 5 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Adverio's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Adasky
Adasky, Ltd.
21 patents
- Adherium (NZ)
Adherium (NZ) Limited
21 patents
- Aduro Biotech
Aduro BioTech Inc.
21 patents
- Advanced Fusion S…
Advanced Fusion Systems LLC
21 patents
- Air Squared
Air Squared, Inc.
21 patents
- Airborne Athletics
Airborne Athletics, Inc.
21 patents
- All Systems Broad…
All Systems Broadband, Inc.
21 patents
- Allurion
Allurion Technologies, LLC
21 patents
- Adverio Pharma ◀
Adverio Pharma GmbH
21 patents
What this shows Adverio holds 21 patents at rank #13,857, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Adverio
By rank, the assignees closest to #13,857 in granted patent volume.
- Adasky, Ltd. #13,853 · 21 patents
- Adherium (NZ) Limited #13,854 · 21 patents
- Aduro BioTech Inc. #13,855 · 21 patents
- Advanced Fusion Systems LLC #13,856 · 21 patents
- Air Squared, Inc. #13,858 · 21 patents
- Airborne Athletics, Inc. #13,859 · 21 patents
- All Systems Broadband, Inc. #13,860 · 21 patents
- Allurion Technologies, LLC #13,861 · 21 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Adverio's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Adverio's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 39th percentile higher than 39% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 4.8% |
| 2016 | 1 | 4.8% |
| 2017 | 2 | 9.5% |
| 2018 | 3 | 14.3% |
| 2019 | 3 | 14.3% |
| 2020 | 5 | 23.8% |
| 2021 | 1 | 4.8% |
| 2022 | 2 | 9.5% |
| 2023 | 1 | 4.8% |
| 2024 | 2 | 9.5% |
Which technologies does Adverio Pharma GmbH patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Adverio Pharma GmbH's patent record in context - here's where to go next.
- Adverio Pharma GmbH's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 95.2% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #13,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Adverio Pharma GmbH against Adasky, Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.